Our aim was to analyze the influence of subtle cochlear damage on temporal auditory resolution in tinnitus patients. Forty-eight subjects (hearing threshold ≤25 dB HL) were assigned to one of two experimental groups: 28 without auditory complaints (mean age, 28.8 years) and 20 with tinnitus (mean age, 33.5 years). We analyzed distortion product otoacoustic emission growth functions (by threshold, slope, and estimated amplitude), extended high-frequency thresholds, and the Gaps-in-Noise test. There were differences between the groups, principally in the extended high-frequency thresholds and the Gaps-in-Noise test results. Our findings suggest that subtle peripheral hearing impairment affects temporal resolution in tinnitus, even when pure-tone thresholds as conventionally measured appear normal.

Keywords:
Tinnitus, Otoacoustic emissions, Hearing tests, Auditory perception, Temporal resolution
1.
Ami M, Abdullah A, Awang MA, Liyab B, Dip, Saim L: Relation of distortion product otoacoustic emission with tinnitus. Laryngoscope 2008;118:712–717.
2.
Baguley DM: Mechanisms of tinnitus. Br Med Bull 2002;63:195–212.
3.
Bartels H, Staal MJ, Albers WJ: Tinnitus and neural plasticity of brain. Otol Neurotol 2007;28:178–184.
4.
Burguetti FAR, Peloggia AG, Carvallo RMM: Limiares de Audibilidade em Altas Freqüências em Indivíduos com Queixa de Zumbido (in Portuguese). Arq Otorrinolaringol 2004;8:277–283.
5.
Chen GD, Tanaka C, Henderson D: Relation between outer hair cell loss and hearing loss in rats exposed to styrene. Hear Res 2008;243:28–34.
6.
Chermak GD, Musiek FE: Central Auditory Processing Disorders – New Perspectives. San Diego, Singular Publishing Group, 1997.
7.
Dorn PA, Konrad-Martin D, Neely ST, Keefe DH, Cyr E, Gorga MP: Distortion product otoacoustic emission input/output functions in normal-hearing and hearing-impaired human ears. J Acoust Soc Am 2001;110:3119–3131.
8.
Eggermont JJ, Roberts LE: The neuroscience of tinnitus. Trends Neurosci 2004;27:676–682.
9.
Fitzgibbons PJ, Wightman FL: Gap detection in normal and hearing-impaired listeners. J Acoust Soc Am 1982;72:761–765.
10.
Glasberg BR, Moore BCJ, Bacon SP: Gap detection and masking in hearing-impaired and normal-hearing subjects. J Acoust Soc Am 1987;81:1546–1556.
11.
Gorga MP, Neely ST, Dierking DM, Kopun J, Jolkowski K, Groenenboom K, Tan H, Stiegemann B: Low-frequency and high-frequency cochlear nonlinearity in humans. J Acoust Soc Am 2007;122:1671.
12.
Gorga MP, Neely ST, Dorn PA, Konrad-Martin D: The use of distortion product otoacoustic emission suppression as an estimate of response growth. J Acoust Soc Am 2002;111:271–284.
13.
Gouveris H, Maurer J, E Mann W: DPOAE-grams in patients with acute tonal tinnitus. Otolaryngol Head Neck Surg 2005;132:550–553.
14.
Hesse G, Schaaf H, Laubert A: Specific findings in distortion product otoacoustic emissions and growth functions with chronic tinnitus. Int Tinnitus J 2005;11:6–13.
15.
Janssen T, Kummer P, Arnold W: Growth behavior of the 2 f1-f2 distortion product otoacoustic emission in tinnitus. J Acoust Soc Am 1998;103:3418–3430.
16.
Jastreboff PJ: Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 1990;8:221–254.
17.
Job A, Raynal M, Kossowski M: Susceptibility to tinnitus revealed at 2 kHz range by bilateral lower DPOAEs in normal hearing subjects with noise exposure. Audiol Neurootol 2007;12:137–144.
18.
Kaltenbach JA: Insights on the origins of tinnitus: an overview of recent research. Hear J 2009;62:26–29.
19.
Kaltenbach JA, Zhang J, Finlayson P: Tinnitus as a plastic phenomenon and its possible neural underpinnings in the dorsal cochlear nucleus. Hear Res 2005;206:200–226.
20.
Kummer P, Janssen T, Arnold W: The level and growth behavior of the 2 f1-f2 distortion product otoacoustic emission and its relationship to auditory sensitivity in normal hearing and cochlear hearing loss. J Acoust Soc Am 1998;103:3431–3444.
21.
Lockwood AH, Salvi RJ, Burkard RF: Tinnitus. N Engl J Med 2002;347:904–910.
22.
Lockwood AH, Salvi RJ, Coad ML, Towsley ML, Wack DS, Murphy BW: The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology 1998;50:114–120.
23.
Lorenzi C, Gilbert G, Carn H, Garnier S, Moore BC: Speech perception problems of the hearing impaired reflect inability to use temporal fine structure. Proc Natl Acad Sci USA 2006;103:18866–18869.
24.
Moore BC, Glasberg BR: Gap detection with sinusoids and noise in normal, impaired, and electrically stimulated ears. J Acoust Soc Am 1988;83:1093–1101.
25.
Moore BC, Oxenham AJ: Psychoacoustic consequences of compression in the peripheral auditory system. Psychol Rev 1998;105:108–124.
26.
Moreira RR, Ferreira Junior M: Speech tests: application in individuals with noise induced hearing loss (in Portuguese). Pro Fono 2004;16:293–300.
27.
Mühlnickel W, Elbert T, Taub E, Flor H: Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA 1998;95:10340–10343.
28.
Musiek FE, Shinn JB, Jirsa R, Bamiou DE, Baran JA, Zaidan E: GIN (Gaps-In-Noise) test performance in subjects with confirmed central auditory nervous system involvement. Ear Hear 2005;26:608–618.
29.
Neely ST, Gorga MP, Dorn PA: Cochlear compression estimates from measurements of distortion-product otoacoustic emission. J Acoust Soc Am 2003;114:1499–1507.
30.
Onishi ET, Fukuda Y, Suzuki FA: Distortion product otoacoustic emissions in tinnitus patients. Int Tinnitus J 2004;10:13–16.
31.
Oxenham AJ, Bacon SP: Cochlear compression: perceptual measures and implications for normal and impaired hearing. Ear Hear 2003;24:352–366.
32.
Ozimek E, Wicher A, Szyfter W, Szymiec E: Distortion product otoacoustic emission (DPOAE) in tinnitus patients. J Acoust Soc Am 2006;119:527–538.
33.
Rawool VW: The effects of hearing loss on temporal processing. 2. Looking beyond simple audition. Hear Rev 2006;13:30, 32, 34.
34.
Ruggero M, Rich N, Recio A, Naryan SS, Robles L: Basilar-membrane responses to tones at the base of the chinchilla cochlea. J Acoust Soc Am 1997;101:2151–2163.
35.
Samelli AG, Schochat E: The Gaps-in-Noise test: gap detection threshold in normal-hearing young adults. Int J Audiol 2008;47:238–245.
36.
Sanchez TG, Medeiros IR, Levy CP, Ramalho Jda R, Bento RF: Tinnitus in normally hearing patients: clinical aspects and repercussions. Braz J Otorhinolaryngol 2005;71:427–431.
37.
Schatteman TA, Hughes LF, Caspary DM: Aged-related loss of temporal processing: altered responses to amplitude modulated tones in rat dorsal cochlear nucleus. Neuroscience 2008;154:329–337.
38.
Seki S, Eggermont JJ: Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after localized tone-induced hearing loss. Hear Res 2003;180:28–38.
39.
Shiomi Y, Tsuji J, Naito Y, Fujiki N, Yamamoto N: Characteristics of DPOAE audiogram in tinnitus patients. Hear Res 1997;108:83–88.
40.
Weihing JA, Musiek FE, Shinn JB: The effect of presentation level on the Gaps-In-Noise (GIN) test. J Am Acad Audiol 2007;18:141–150.
41.
Weisz N, Hartmann T, Dohrmann K, Schlee W, Norena A: High-frequency tinnitus does not mean absence of deafferentation. Hear Res 2006;222:108–114.
42.
Weisz N, Müller S, Schlee W, Dohrmann K, Hartmann T, Elbert T: The neural code of auditory phantom perception. J Neurosci 2007;27:1479–1484.
43.
Williams EJ, Bacon SP: Compression estimates using behavioral and otoacoustic emissions measures. Hear Res 2005;201:44–54.
44.
Zamyslowska-Szmytke E, Fuente A, Niebudek-Bogusz E, Sliwinska-Kowalska M: Temporal processing disorder associated with styrene exposure. Audiol Neurootol 2009;14:296–302.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.